Drug of choice for chronic myeloid leukemia:
Ans. D. CisplatinImatinib is tyrosine kinase inhibitor which act due to bcr-abl fusion. It is drug of choice for CMI and GIST. Methotrexate is drug of choice for choriocarcinoma. Sunitib can be given for renal cell carcinoma. Cisplatin is indicated for solid tumors.
Imatinib
Methotrexate
Sunitinib
Cisplatin
Anti-Cancer